Press Releases

16/24/16 Orthocell reports 98.6% success rate in Striate+â„¢ dental membrane study AQ
23/24/23 Orthocell raising $3.5 million; adds heavy hitters to register AQ
02/23/02 Orthocell on the cusp of significant growth AQ
29/23/29 Orthocell thrilled to welcome John Van Der Wielen as chairman AQ
31/23/31 Orthocell welcomes globally recognised nerve surgeons to advisory board AQ
08/23/08 Orthocell welcomes high profile US-based healthcare specialist to the board AQ
21/22/21 Orthocell : Notification regarding unquoted securities - OCC PU
30/21/30 Orthocell : Application for quotation of securities - OCC PU
23/21/23 Orthocell : Application for quotation of securities - OCC PU
16/21/16 Orthocell : Application for quotation of securities - OCC PU
08/21/08 Orthocell : OrthoATI Tendon Clinical Study Success PU
18/21/18 Orthocell : Application for quotation of securities - OCC PU
09/21/09 Application for quotation of securities - OCC PU
15/21/15 Orthocell : Receives US Market Clearance BU
05/18/05 Orthocell : Positive Pre-Clinical Results Using CelGro® in Anterior Cruciate Ligament (ACL) Reconstruction BU
18/18/18 Orthocell : Secures New Patent for Suture-Less Repair of Soft Tissue BU
15/17/15 Orthocell : Granted European Tendon Regeneration Patent BU
07/17/07 Orthocell : Commences Treatment of Its 1,000th Patient BU
09/17/09 Orthocell : Receives CE Mark for CelGro® BU
11/17/11 Orthocell : Appoints Surgical Specialties as Exclusive Distributor BU
05/17/05 Orthocell : 1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study BU
12/17/12 Orthocell : Announces Collaboration with Johnson & Johnson Innovation BU
18/16/18 Orthocell : Receives Approval for Human Nerve Regeneration Study Using CelGro® BU
04/16/04 Orthocell : Professor Rocky Tuan Appointed to Orthocell Advisory Board BU
05/16/05 Orthocell : ‘Cell Factory’ Granted Patent in US BU
No results for this search